These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 37724258)
1. Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives. Liu L; Chen J Med Rev (2021); 2022 Dec; 2(6):555-569. PubMed ID: 37724258 [TBL] [Abstract][Full Text] [Related]
2. Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. Shin C; Kim SS; Jo YH Mol Ther Oncolytics; 2021 Sep; 22():166-179. PubMed ID: 34514097 [TBL] [Abstract][Full Text] [Related]
4. Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Runcie K; Budman DR; John V; Seetharamu N Mol Med; 2018 Sep; 24(1):50. PubMed ID: 30249178 [TBL] [Abstract][Full Text] [Related]
5. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy. Cho SF; Anderson KC; Tai YT Front Immunol; 2018; 9():1821. PubMed ID: 30147690 [TBL] [Abstract][Full Text] [Related]
6. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA. Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809 [TBL] [Abstract][Full Text] [Related]
7. Trispecific antibodies for cancer immunotherapy. Yao Y; Hu Y; Wang F Immunology; 2023 Aug; 169(4):389-399. PubMed ID: 36855956 [TBL] [Abstract][Full Text] [Related]
8. Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy. Li T; Wang X; Niu M; Wang M; Zhou J; Wu K; Yi M Front Immunol; 2023; 14():1196970. PubMed ID: 37520520 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in multiple myeloma. Jadoon Y; Siddiqui MA Cancer Treat Res Commun; 2021; 29():100468. PubMed ID: 34653747 [TBL] [Abstract][Full Text] [Related]
10. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA. Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM MAbs; 2012; 4(6):648-52. PubMed ID: 23007482 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology. Mihăilă RG Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510 [TBL] [Abstract][Full Text] [Related]
12. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Yasunaga M Semin Cancer Biol; 2020 Aug; 64():1-12. PubMed ID: 31181267 [TBL] [Abstract][Full Text] [Related]
13. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy. Chung C Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103 [TBL] [Abstract][Full Text] [Related]